OPIOID SCANDAL IN THE USA REVEALED THE NAMES OF OWNERS FROM RUSSIA

In early August, Buxton Helmsley Group, which manages Mallinckrodt's assets, released information on its major shareholders. They own the main shares of the enterprise, which turned out to be a participant in the opioid drama in the United States. It turned out that out of 31 people, 13 are citizens of Russia.

Information about investors is part of the information that Buxton Helmsley submitted to the US Securities and Exchange Commission (SEC). The personal data of some of the participants coincided with the characteristics of the well-known entrepreneurs Valery Mansurov (owns a construction business in Ufa) and Vanik Petrosyan (a restaurateur from Kislovodsk).

According to some experts, in fact, there can be much more Russian shareholders, since the names of many minority shareholders have not yet been disclosed.

In an interview with RBC, one of the partners of Buxton Helmsley Group estimated the share of Russians at 10-20% of the total capital of Mallinckrodt.

Mallinckrodt was named after the brothers who founded their business in 1867. Although the company operates primarily in America, it was officially registered in Ireland. The company develops and produces medical products containing components identical to those previously patented (‘generics’).

The company's troubles began in 2019, when it became involved in a scandal caused by an avalanche of lawsuits and government intervention. Excessive marketing activity has resulted in multimillion-dollar fines and legal costs for companies.

As a result, Mallinckrodt filed for bankruptcy in October 2020.

In April 2021, Rusbankrot already published a material about the precarious position of Mallinckrodt, which had suffered losses for three years. The last time the company showed profit was in 2017, but now the main problem of minority shareholders is to try to protect their rights in a dispute with the company's management. Among the claims published by Buxton Helmsley is the lack of notification to shareholders when filing for bankruptcy.

The company itself conveyed to investors that it plans to cancel all securities after the end of the restructuring process. This could mean that investors (owners of stocks and unsecured bonds) will receive almost nothing. It is known that on August 13, the Mallinckrodt shareholders' meeting voted to change the company's management, but this will not happen soon, while the restructuring plan will be considered by the court in Delaware on September 21.